IL1B and COVID-19: In addition to high early IFN responses, moderate COVID-19 is associated with increased plasma levels of a core of pro-inflammatory cytokines, chemokines and growth factors (e.g., IL-1a, IL-1β, IFNα, IL-12p70, and IL-17A) that are effectively resolved during infection10.